Search Results

NQ301 100mg  | ≥98%

CSNpharm

NQ301, a selective CD45 inhibitor with an IC50 of 200 nM, is also an antithrombotic agent and inhibits collagen-challenged rabbit platelet aggregation with an IC50 of 10 mg/mL.

More Information Supplier Page

NQ301 25mg  | ≥98%

CSNpharm

NQ301, a selective CD45 inhibitor with an IC50 of 200 nM, is also an antithrombotic agent and inhibits collagen-challenged rabbit platelet aggregation with an IC50 of 10 mg/mL.

More Information Supplier Page

NQ301 5mg  | ≥98%

CSNpharm

NQ301, a selective CD45 inhibitor with an IC50 of 200 nM, is also an antithrombotic agent and inhibits collagen-challenged rabbit platelet aggregation with an IC50 of 10 mg/mL.

More Information Supplier Page

NQ301 50mg  | ≥98%

CSNpharm

NQ301, a selective CD45 inhibitor with an IC50 of 200 nM, is also an antithrombotic agent and inhibits collagen-challenged rabbit platelet aggregation with an IC50 of 10 mg/mL.

More Information Supplier Page

HTHQ 100mg  | ≥99%

CSNpharm

HTHQ, which is a hydroquinone monoalkyl ether, is a potent anti-oxidative agent, even at low dose levels.

More Information Supplier Page

HTHQ 5mg  | ≥99%

CSNpharm

HTHQ, which is a hydroquinone monoalkyl ether, is a potent anti-oxidative agent, even at low dose levels.

More Information Supplier Page

NQ301 10mg  | ≥98%

CSNpharm

NQ301, a selective CD45 inhibitor with an IC50 of 200 nM, is also an antithrombotic agent and inhibits collagen-challenged rabbit platelet aggregation with an IC50 of 10 mg/mL.

More Information Supplier Page